digestive enzymes with glp 1 While on GLP-1: Safety and Evidence Upper & Lower GI Kit

Semaglutide has demonstrated the capacity to decrease both recurrent alcohol consumption and total alcohol intake in rats by over 50% (Aranas et al., 2023)

As GLP1 therapies expand into pediatric care, a growing number of providers are asking how to best implement them in adolescents diagnosed with both type 2 diabetes and obesity

The food-reward pathways are more effectively dampened

Pillars such as sleep, stress management, substance use, social support, spiritual, and environmental aspects of someones life are important to consider when trying to help guide them to a more balanced and vivacious life

Information on dose, treatment duration, titration, and discontinuation were not systematically available

The oral GLP-1 market has changed faster in the past six months than in the previous six years